Abstract
A rhodamine-iridium (III) complex bearing indomethacin moiety, named IM-rho-Ir, was synthesized and evaluated for COX-2 targetable photodynamic therapy. By integrating COX-2 directing group, IM-rho-Ir exhibited enhanced cellular uptake in cancer cells than in normal cells compared to rhodamine-iridium (III) complex without indomethacin moiety.
Keywords:
COX-2; Photodynamic therapy; Photosensitizer; Rhodamine.
Copyright © 2021 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Coordination Complexes / chemical synthesis
-
Coordination Complexes / chemistry
-
Coordination Complexes / pharmacology*
-
Cyclooxygenase 2 / metabolism
-
Cyclooxygenase 2 Inhibitors / chemical synthesis
-
Cyclooxygenase 2 Inhibitors / chemistry
-
Cyclooxygenase 2 Inhibitors / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Female
-
Humans
-
Indomethacin / chemistry
-
Indomethacin / pharmacology
-
Iridium / chemistry
-
Iridium / pharmacology
-
MCF-7 Cells
-
Mammary Neoplasms, Experimental / drug therapy
-
Mammary Neoplasms, Experimental / metabolism
-
Mammary Neoplasms, Experimental / pathology
-
Mice
-
Mice, Nude
-
Molecular Structure
-
Photochemotherapy*
-
Photosensitizing Agents / chemical synthesis
-
Photosensitizing Agents / chemistry
-
Photosensitizing Agents / pharmacology*
-
Rhodamines / chemistry
-
Rhodamines / pharmacology
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Coordination Complexes
-
Cyclooxygenase 2 Inhibitors
-
Photosensitizing Agents
-
Rhodamines
-
Iridium
-
Cyclooxygenase 2
-
Indomethacin